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Background: Complement activation products are present in atherosclerotic plaques. Recently, binding of
complement to elastin and collagen in the aortic wall has been demonstrated, suggesting a role of complement in
the development aortic stiffness and atherosclerosis. The definitive role of complement in atherosclerosis and
arteriosclerosis, however, remains unclear.
Case presentation: We here describe a patient with hereditary complete deficiency of complement C4 suffering
from Henoch-Schoenlein purpura and on renal replacement therapy for twenty-eight years. The patient had the full
range of risk factors for vascular damage such as hypertension, volume overload, hyperphosphatemia and
hyperparathyroidism. Despite that, his carotid artery intima media thickness was below the normal range and his
pulse wave velocity was normal. In contrast, the patient’s coronary and peripheral muscular arteries were heavily
calcified.
Conclusion: This case supports the hypothesis that complement plays an important role in the development of
stiffness of elastic arteries. We speculate that inability to activate complement by the classical or lectin pathways
protected the patient from atherosclerosis, arteriosclerosis, stiffening and calcification of the aorta and carotid
arteries. Inhibition of complement activation may be a potential target for prophylactic and therapeutic
interventions.
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Accelerated vascular calcification and vascular stiffening
are common in end-stage renal disease (ESRD) [1-3].
Both are associated with mortality in the CKD and
ESRD population [4]. No effective therapeutic strategy is
available to prevent or slow down vascular calcification
und arterial stiffening in patients with chronic kidney
disease. It has recently been shown that complement
components C3 and C4 bind to elastic and collagen
fibers in the mouse aorta, and it was postulated that
complement may play a central role in progressive vas-
cular stiffening of elastic arteries [5]. We here describe a
patient who, despite having multiple risk factors, does
not show any signs of arteriosclerosis or atherosclerosis* Correspondence: florian.knoll@lkhf.at
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reproduction in any medium, provided the orof his central elastic arteries after 28 years of renal re-
placement therapy. This unexpected finding is poten-
tially related to the primary disease of the patient:




The patient suffered from Henoch-Schoenlein purpura
with severe renal involvement from the age of seventeen.
From 1984 to 1985, aged 23 years, he underwent
hemodialysis treatment. In 1985, he received his first renal
allograft. Transplant function deteriorated because of
interstitial fibrosis/tubular atrophy and recurrence of his
primary disease. Immunofluorescence of the biopsies of
the patient’s own kidneys and the transplant showed
granular deposits of IgG, IgM, IgA and C3 in the mesan-
gium and along the glomerular capillary walls. Staining ford. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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went hemodialysis. In 1996 a total parathyroidectomy with
autotransplantation into the right brachioradial muscle
was performed for severe hyperparathyroidism with a
PTH of 820 pg/ml, hypercalcemia and hyperphosphate-
mia. After surgery PTH levels remained between 50 and
100 pg/ml. In 1997, a second renal transplantation was
performed. In 2006, allograft function deteriorated and a
transplant biopsy revealed advanced calcineurin inhibitor-
associated arteriolopathy. Hyperphosphatemia despite
treatment with various phosphate binders and a tendency
to hypercalcemia were present during the years with
reduced transplant function since 2006. Despite advanced
renal failure, marked hypertension due to extensive fluid
overload and despite severe hyperphosphatemia the pa-
tient refused to initiate dialysis until July 2011. Table 1
shows laboratory values and medications at commence-
ment of dialysis.
Investigation of arterial vessels
At age 51 the patient underwent ultrasound of the carotid
arteries as part of pre-transplant evaluation for a third kid-
ney transplantation. Figure 1 shows the structure of the
wall of both common carotid arteries to be completely
normal without atherosclerotic plaques. The carotid artery
intima-media thickness (CIMT) was 0.44 mm for the right
common carotid artery (CCA) and 0.50 mm for the left
CCA, thus on both sides clearly below the upper limit of
0.71 mm for a healthy population of the same age [7]. In
addition, we assessed aortic augmentation index (Figure 2)
and carotid-femoral pulse-wave velocity (PWV) using the
Sphygmocor™ system (AtCor Medical, Sydney, Australia).
The patient’s PWV of 5.3 ± 0.1 m/s is expected in a
healthy adolescent, but is highly unusual in a patient who
has been on renal replacement therapy for almost three
decades. As a mean PWV a reference value of 11.6 ±
3.3 m/s has been proposed for patients with CKD 5 [8].











LDL 72 mg/dlrays and in ultrasound investigations of the abdominal
aorta and no signs of valvular calcifications in an
echocardiography.
X-ray examinations of the patient’s hands and right foot
(Figure 3) for joint pain revealed advanced calcification of
the anterior and posterior tibial and plantar arteries and
the radial artery, a finding to be expected in a patient with
long-lasting kidney disease. Duplex ultrasound examin-
ation of peripheral muscular arteries (Figure 4) confirmed
the presence of abundant vessel wall calcifications. The ar-
terial blood flow signal was normal without signs of vascu-
lar stenosis. Computed tomography of the coronary
arteries revealed severe calcification with an Agatston
score of 782.5 corresponding to the 99th percentile of age
and gender matched controls [9]. Co-illustrated slices of
the aorta were free of calcification.Complement C4 deficiency
The patient’s primary disease is hereditary complete defi-
ciency of complement C4, and C4 was never detected in
his serum on multiple occasions. The human comple-
ment C4 genes are located on chromosome 6 in the
major histocompatibility complex region. They encode
for two highly polymorphic isoforms, C4A and C4B.
Hereditary complete C4 deficiency is exceptionally rare
with less than 30 patients having been reported. Most of
them suffered from a lupus-like illness. Our patient is
homozygous for the MHC haplotype HLA A30 B18
DR7. This haplotype does not contain C4A genes, but
instead two mutant short C4B genes with a 8127 g→ a
point mutation at the donor site of the intron 28 splice
junction, which abrogates correct RNA splicing [10].
Splicing according to a new potential donor site seven
nucleotides downstream would lead to a stop codon in
exon 29. These results and the absence of C4 from our
patient’s serum strongly suggest that he was completely
C4-deficient.started hemodialysis 2011
Medication Daily dose
Sodium bicarbonate 1 g
Calcium carbonate 3 g
Lanthanum carbonate 2250 mg





Darbepoietin 40 μg once weekly
Figure 1 B-mode carotid duplex ultrasound. Right (right picture) and left (left picture) common carotid artery (CCA): no plaques and a normal
carotid intima media thickness of 0.44 mm for the right CCA and 0.50 mm for the left CCA (upper limit of normal for age 50–59 years: 0.71 mm)
as evidence of the absence of atherosclerosis and arteriosclerosis.
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Arteriosclerosis of central and peripheral arteries is the
hallmark of the vasculopathy of chronic kidney disease.
In addition to traditional risk factors, CKD-specific fac-
tors such as electrolyte abnormalities seem to drive vas-
cular pathology in these patients. Our patient with
almost 30 years of renal replacement therapy does not
fit into this scheme. As expected, his coronary and per-
ipheral muscular arteries were heavily calcified. He had,
however, well preserved central elastic arteries.
It is highly unusual to find completely normal carotid
vessels without intimal hyperplasia or atherosclerotic
plaques and without calcification of the media in a pa-
tient who has been on renal replacement therapy for so
long, including ten years of hemodialysis. The finding of
a PWV of 5.2 m/s corresponds to the PWV of a young
adult without arteriosclerosis of the aorta and is also
unexpected [11]. He had suffered from the whole array
of conditions that are thought to cause the vasculopathy
of chronic kidney disease. The efficacy of theseFigure 2 Central aortic pulse wave. No signs of arterial stiffness as indica
pressure was 125/65 mmHg, pulse pressure 60 mmHg; central aortic systol
pressure 46 ± 1 mmHg; aortic augmentation pressure 11.5 ± 1.5 mmHg, aormechanisms is clearly illustrated by the calcifications of
coronary and peripheral vessels. We believe that the
patient’s primary disease, complement C4 deficiency, can
explain these unusual findings.C4 and atherosclerosis
How might C4 deficiency protect against atheroscler-
osis? C4 is a main component of the classical and lectin
pathways of complement. Without doubt, complement
plays a role in the development of atherosclerosis. Ter-
minal complement complex C5b-9 is regularly detected
in atherosclerotic lesions [12]. In animal models, C6 de-
ficiency protects against plaque formation [13]. Classical
pathway activation may occur by several mechanisms in
atherosclerosis. C-reactive protein, also present in
lesions, is a potent activator of the classical pathway
[14]. In addition, activation can be triggered by immune
complexes containing autoantibodies against oxidized
LDL and heat shock proteins [15].ted by low central pulse pressure augmentation. Brachial blood
ic/diastolic blood pressure 112 ± 1/66 ± 0 mmHg, central aortic pulse
tic augmentation index 25 ± 2%.
Figure 3 X-ray of right ankle. Severe calcification of the anterior
and posterior tibial and plantar arteries is evident (white arrows).
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Even more intriguing is the total absence of arterioscler-
osis of central elastic arteries in this patient with C4 de-
ficiency. Recent studies in mice support a role of
complement in arteriosclerosis of these vessels [5]. It has
been shown that complement components C3 and C4
are deposited along collagen and elastin fibers in theFigure 4 Duplex ultrasound and PW-Doppler sonography of
right posterior tibial artery: severe calcification of the vascular
wall and normal non-stenotic flow signal.external elastic lamina of the aorta. These complement
components are most likely derived from the perivascu-
lar adipose tissue of the aorta. Complement deposition
increases with age and parallels vascular stiffening. In
atherosclerosis-prone ApE(−/−) mice complement de-
position extends into the media and intimal plaques.
How C3 and C4 are deposited along collagen and elastin
remains unclear. Spontaneously hydrolyzed C3 and C4
may attach covalently to the fibers. Alternatively, fibro-
modulin and adiponectin, which bind to collagen fibers
in vessel walls [16,17], also bind to C1q and activate the
classical complement pathway [18,19], which then would
lead to complement deposition. As C4 is the central
component of the classical pathway, the findings in our
patient with C4 deficiency would favor the second
mechanism and suggest that complement deposition in
the vessel wall is mediated by the classical or lectin path-
way. How complement activation eventually leads to
vascular stiffening and calcification, remains to be deter-
mined. Complement fragments may attract leucocytes to
the vascular wall, where they may be activated by com-
plement and secrete proinflammatory cytokines. Ele-
vated levels of interleukin-6 and tumor necrosis factor-
alpha in the circulation are associated with vascular
calcification in patients with chronic kidney disease [20].
They are also associated with low levels of fetuin-a, a po-
tent inhibitor of calcification [21]. Complement activa-
tion may create a local environment in the vessel wall
that strongly favors calcification. In an animal model of
diabetes collagen synthesis and ventricular stiffening in
the heart have been shown to be dependent on
mannose-binding lectin and activation of the lectin path-
way [22]. Likewise, a complement C5a receptor antagon-
ist prevented cellular infiltration, fibrosis and stiffening
of the heart in DOCA-salt hypertensive rats [23]. In ana-
logy, complement activation may also accelerate fibrosis
and stiffening of the central elastic vessels. Recently C4d
deposits in the adventitia have been found in 50% of
patients undergoing surgery of the ascending aorta. Lack
of C4d staining was associated with aortic dissection.
Whether complement may have a protective role against
aortic dissection remains speculative [24].
Conclusion
Our observations – normal central arteries but advanced
calcification of coronary and muscular arteries - also
would imply that arteriosclerosis of central elastic and per-
ipheral muscular arteries (including coronary arteries) are
driven by separate mechanisms. Whereas arteriosclerosis
seems to be complement-dependent in elastic arteries, the
process might be complement-independent in muscular
arteries. Clearly, further research is needed to unravel the
role of the complement system in atherosclerosis and ar-
teriosclerosis. In addition, inhibition of complement
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therapeutic interventions.
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